FAA clarifies diabetes and neurofibromatosis workflows in AME guide
Feb 27, 2026
Feb 27, 2026
FAA updated AME guide language to rename diabetes/hyperglycemia worksheets to include injectable GLP-1 agents (non-insulin injectables) and clarified that insulin use triggers a separate workflow; it also moved neurofibromatosis type 1 to an AASI with a neurologist progress note current within 90 days.
The full story
The Federal Aviation Administration clarified two noncardiac medical-workflow updates for Aviation Medical Examiners during the January Grand Rounds.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
or
Free account
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in →